The abstract is read at the publisher; the summary is JClub's.
In rat astrocytes, 6-day exposure to 200 nM atorvastatin or simvastatin lowers the total mtCoQ pool by 30–35% and disrupts mitochondrial bioenergetics.
- Why it matters: Statins may impair mitochondrial function by reducing CoQ biosynthesis, and astrocytes are key to brain redox balance, so mtCoQ-linked dysfunction could underlie CNS pathology.
- What they did: The study treated rat astrocytes with 200 nM atorvastatin or simvastatin for 6 days, then measured mtCoQ pools, respiratory chain organization, complex activities, membrane potential, ATP synthesis, and mtH2O2 production.
- The result: Statin-treated mitochondria showed reduced respiration, membrane potential, and ATP synthesis, with increased mtCoQ reduction and H2O2 during CI and CII substrate oxidation; CoQ10 supplementation restored mtCoQ levels and respiratory function while lowering mtH2O2 and mtQ reduction.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.